UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 06/2018, Volume 32, Issue 6, pp. 274 - 275
Journal Article
JCO clinical cancer informatics, ISSN 2473-4276, 04/2020, Volume 4, Issue 4, pp. 318 - 320
Journal Article
The lancet oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
Journal of oncology practice, ISSN 1554-7477, 08/2016, Volume 12, Issue 8, pp. 699 - 700
Journal Article
Clinical cancer research, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 5218 - 5224
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Aminopyridines - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Cyclin-Dependent Kinase 4 - genetics | Humans | Middle Aged | Cyclin-Dependent Kinase 6 - genetics | Aminopyridines - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Drug-Related Side Effects and Adverse Reactions - pathology | Disease-Free Survival | Neoplasm Metastasis | Breast Neoplasms - genetics | Benzimidazoles - administration & dosage | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Benzimidazoles - adverse effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Drug-Related Side Effects and Adverse Reactions - classification | Toxicity | Diarrhea | Fatigue | Nausea | Breast cancer | Metastasis | Cancer therapies | Patients | Survival | ErbB-2 protein | Cyclin-dependent kinase 4 | Metastases | Chemotherapy | Inhibitors | Experimental design | Quality | Medical prognosis | Response rates | Toxic diseases | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2011, Volume 364, Issue 3, pp. 205 - 214
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Deoxycytidine - administration & dosage | Humans | Kaplan-Meier Estimate | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Breast Neoplasms - drug therapy | Poly(ADP-ribose) Polymerase Inhibitors | Cross-Over Studies | Benzamides - therapeutic use | Neoplasm Metastasis - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Breast Neoplasms - mortality | Female | Aged | Benzamides - adverse effects | Deoxycytidine - analogs & derivatives | Antimitotic agents | Usage | Care and treatment | Chemotherapy | Enzyme inhibitors | Gemcitabine | Breast cancer | Genetic aspects | Drug therapy, Combination | Antineoplastic agents | Health aspects | Cancer | DNA methylation | Cancer therapies | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus
Journal Article
JCO clinical cancer informatics, ISSN 2473-4276, 11/2017, Volume 1, Issue 1, pp. 1 - 2
Journal Article
Journal of oncology practice, ISSN 1554-7477, 01/2018, Volume 14, Issue 1, p. 1
Journal Article
The Journal of community and supportive oncology, ISSN 2330-7749, 04/2016, Volume 14, Issue 4, p. 137
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2015, Volume 33, Issue 17, pp. 1889 - 1894
Skin Neoplasms - pathology | Prospective Studies | Skin Neoplasms - drug therapy | Drug Administration Schedule | Follow-Up Studies | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Kaplan-Meier Estimate | Antibodies, Monoclonal - therapeutic use | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Melanoma - secondary | Clinical Trials, Phase III as Topic | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Melanoma - drug therapy | Retrospective Studies | Clinical Trials, Phase II as Topic | Index Medicus | Original Reports
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2005, Volume 23, Issue 30, pp. 7475 - 7482
Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | United States - epidemiology | Breast Neoplasms - radiotherapy | Heart Diseases - etiology | SEER Program | Time Factors | Heart - radiation effects | Radiotherapy, Adjuvant - adverse effects | Humans | Female | Survival Rate | Aged | Index Medicus
Journal Article
The Journal of community and supportive oncology, ISSN 2330-7749, 04/2015, Volume 13, Issue 4, p. 125
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2007, Volume 25, Issue 25, pp. 3871 - 3876
Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Multivariate Analysis | Risk Assessment | Humans | Leukemia, Myeloid, Acute - epidemiology | Myelodysplastic Syndromes - epidemiology | Breast Neoplasms - drug therapy | Incidence | Antineoplastic Agents - adverse effects | Chemotherapy, Adjuvant - adverse effects | Myelodysplastic Syndromes - chemically induced | Aged, 80 and over | Female | Registries | Aged | Leukemia, Myeloid, Acute - chemically induced | Index Medicus
Journal Article
Supportive care in cancer, ISSN 0941-4355, 02/2020, Volume 28, Issue 2, pp. 925 - 932
Health Care Sciences & Services | Oncology | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lung Neoplasms - mortality | Humans | Female | Male | Aged | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Chemotherapy | Drug dosages | Lung cancer | Mortality | Clinical outcomes | Index Medicus | Retrospective studies | Community health services | Original
Journal Article
Journal of oncology practice, ISSN 1554-7477, 10/2018, Volume 14, Issue 10, pp. 577 - 579
Journal Article
Journal of magnetic resonance imaging, ISSN 1053-1807, 09/2018, Volume 48, Issue 3, pp. 695 - 707
breast cancer | diffusion‐weighted MRI | dynamic contrast‐enhanced MRI | T1‐mapping | T1-mapping | dynamic contrast-enhanced MRI | diffusion-weighted MRI | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Radiology | Analysis | Radiology, Medical | Medical research | Adipose tissue | Statistical analysis | Communities | Clinical trials | Breast cancer | Mapping | Statistical tests | Field strength | Accuracy | Maps | Magnetic resonance imaging | Reproducibility | Diffusion coefficient | Cancer
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2018, Volume 36, Issue 26, pp. 2736 - 2740
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 11/2015, Volume 56, Issue 11, pp. 3143 - 3149
Disease progression | health economics | Hodgkin lymphoma | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Recurrence | Humans | Middle Aged | Hodgkin Disease - diagnosis | Male | Hodgkin Disease - epidemiology | Health Expenditures | Disease Progression | Young Adult | Retreatment | Health Care Costs | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged, 80 and over | Hodgkin Disease - drug therapy | Adult | Female | Aged | Retrospective Studies | Neoplasm Staging | Index Medicus
Journal Article
The Journal of community and supportive oncology, ISSN 2330-7749, 04/2014, Volume 12, Issue 4, pp. 111 - 112
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2014, Volume 32, Issue 19, pp. 2078 - 2099
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Triazoles - administration & dosage | Health Status Disparities | United States | Humans | Ado-Trastuzumab Emtansine | Receptors, Estrogen - analysis | Nitriles - administration & dosage | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Societies, Medical | Female | Quinazolines - administration & dosage | Clinical Trials as Topic - standards | Lapatinib | Molecular Targeted Therapy - methods | Drug Administration Schedule | Anastrozole | Biomarkers, Tumor - analysis | Comorbidity | Maytansine - analogs & derivatives | Antineoplastic Agents, Hormonal - administration & dosage | Docetaxel | Treatment Outcome | Evidence-Based Medicine | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | Maytansine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Healthcare Disparities | Breast Neoplasms - mortality | Receptor, ErbB-2 - analysis | Letrozole | Trastuzumab | Index Medicus | ASCO Special
Journal Article